These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15879867)

  • 1. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
    Martins AC; Cologna AJ; Tucci S; Suaid HJ; Falconi RA
    J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
    Takei K; Watanabe H; Itoi T; Saito T
    Pathol Int; 1996 Nov; 46(11):908-17. PubMed ID: 8970203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperadrenalism in childhood and adolescence.
    Thomas CG; Smith AT; Griffith JM; Askin FB
    Ann Surg; 1984 May; 199(5):538-48. PubMed ID: 6721603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
    Takei K; Watanabe H; Itoi T; Saito T
    Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.
    Vargas MP; Vargas HI; Kleiner DE; Merino MJ
    Am J Surg Pathol; 1997 May; 21(5):556-62. PubMed ID: 9158680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
    Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
    Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of monoclonal antibodies (PC 10, MIB1, p53 and LeuM 1) for assessing the prognosis of patients with squamous epithelial carcinoma of the larynx after partial laser resection].
    Hake R; Eckel H; von Pritzbuer E; Volling P; Thiele J
    Pathologe; 1995 May; 16(3):197-203. PubMed ID: 7792271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of endoscopic biopsy using immunostaining of p53 and Ki-67 in tumors of the ampulla of Vater.
    Kubota K; Kakuta Y; Kawamura S; Saito S; Seki H; Kuniyoshi T
    Pathol Int; 2003 Jun; 53(6):361-70. PubMed ID: 12787310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.
    Bernini GP; Moretti A; Viacava P; Bonadio AG; Iacconi P; Miccoli P; Salvetti A
    Br J Cancer; 2002 May; 86(10):1561-5. PubMed ID: 12085205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
    Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
    J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical tumors in children.
    Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
    J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
    Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
    Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperatively irradiated rectal carcinoma: analysis of the histopathologic response and predictive value of proliferating cell nuclear antigen immunostaining.
    Díez M; Ramos P; Medrano MJ; Mugüerza JM; Villeta R; Lozano O; Escribano J; Noguerales F; Ruíz A; Granell J
    Oncology; 2003; 64(3):213-9. PubMed ID: 12697960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase IIα) in borderline ovarian tumors: Correlation with clinicopathological features.
    Ciepliński K; Jóźwik M; Semczuk-Sikora A; Gogacz M; Lewkowicz D; Ignatov A; Semczuk A
    Histol Histopathol; 2018 Feb; 33(2):171-179. PubMed ID: 28493257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
    Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
    Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses.
    Babinska A; Sworczak K; Wisniewski P; Nałecz A; Jaskiewicz K
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):246-51. PubMed ID: 18393131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.